跳至主要内容
临床试验/JPRN-UMIN000023798
JPRN-UMIN000023798已完成2 期

Phase IIb clinical trial of steroid therapy in patients with HAM - HAMLET-P

St. Marianna University School of Medicine Hospital0 个研究点目标入组 8 人开始时间: 2016年8月31日最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Patients who have received corticosteroids or other treatment targeted to HAM within 12 weeks prior to giving informed consent (3)Patients who have undergone invasive surgeries requiring general anesthesia within 24 weeks prior to giving informed consent (4)Patients who have participated in other treatment studies within 16 weeks prior to giving informed consent (5)Patients who have undergone live or attenuated/inactivated vaccinations within four weeks of giving informed consent, or who plan to be vaccinated during the course of the study. (6)Patients taking the ascorbic acid more than 1.5g/day, prosultiamine, or pentosan polysulfate within two weeks of giving informed consent. (7)Patients with a history of acute myocardial infarction (8)Patients with a history of tuberculosis or with active tuberculosis (9)Patients with serious complicating conditions (10)Patients with uncontrolled hypertension (11)Patients with uncontrolled electrolyte imbalance (12)Patients with thrombosis (13)Patients with a history of cancer with complications (14)Patients with peptic ulcer (15)Patients with ATL (16)Patients with poorly controlled eye disease (17)Patients with a history of steroid-induced glaucoma (18)Pregnant or breastfeeding women or patients who may become pregnant or withhold assent to prevention of conception by taking appropriate approach such as condom in cooperation with their partners during the study period (19)Patients in whom assessment with the walk test is difficult or the symptoms can be worsened by the walk test (20)Patients with neurological deficits or findings on MRI suggesting it due to disorders other than HAM

研究者

相似试验